Pharmaceutical Production

Bottling and packaging of sterile medical products. Machine after validation of sterile liquids

Photo by Shutterstock

Pharmaceutical Production
SectorMost major industry classification systems use sources of revenue as their basis for classifying companies into specific sectors, subsectors and industries. In order to group like companies based on their sustainability-related risks and opportunities, SASB created the Sustainable Industry Classification System® (SICS®) and the classification of sectors, subsectors and industries in the SDG Investor Platform is based on SICS.
Health Care
Biotechnology and Pharmaceuticals
Business Model Description

Manufacture pharmaceutical products in solid, semi-solid, liquid and other dosage forms as well as powders, aerosols and ophthalmic eye / ear / nasal drops to serve national and regional markets, leveraging on the country's access to African Continental Free Trade Area (AfCFTA) and preferential trade areas in the region, including Southern African Development Community (SADC) and Common Market for Eastern and Southern Africa (COMESA).

Expected Impact

Enhance affordability of and access to pharmaceutical products, and increase competitiveness and innovation of Mauritius' healthcare industry through technological developments.

Indicative ReturnDescribes the rate of growth an investment is expected to generate within the IOA. The indicative return is identified for the IOA by establishing its Internal Rate of Return (IRR), Return of Investment (ROI) or Gross Profit Margin (GPM).
5% - 10% (in IRR)
Investment TimeframeDescribes the time period in which the IOA will pay-back the invested resources. The estimate is based on asset expected lifetime as the IOA will start generating accumulated positive cash-flows.
Medium Term (5–10 years)
Market SizeDescribes the value of potential addressable market of the IOA. The market size is identified for the IOA by establishing the value in USD, identifying the Compound Annual Growth Rate (CAGR) or providing a numeric unit critical to the IOA.
USD 100 million - USD 1 billion
Average Ticket Size (USD)Describes the USD amount for a typical investment required in the IOA.
> USD 10 million
Direct ImpactDescribes the primary SDG(s) the IOA addresses.
Good health and well-being (SDG 3) Industry, Innovation and Infrastructure (SDG 9) Partnerships For the Goals (SDG 17)
Indirect ImpactDescribes the secondary SDG(s) the IOA addresses.
Decent Work and Economic Growth (SDG 8) Quality Education (SDG 4)
Sector Sources
  • 1) Ministry of Foreign Affairs, Regional Integration and International Trade. 2019. Voluntary National Review Report of Mauritius. 2) International Trade Administration. 2018. Healthcare Resource Guide: Mauritius. 3) Republic of Mauritius - Ministry of Health and Wellness. 2020. Health Sector Strategic Plan 2020-2024. 4) Republic of Mauritius Ministry of Finance, Economic Planning and Development - Statistics Mauritius. 2020. How Do Mauritians Feel About Their Health? 5) Economic Development Board Mauritius. 2021. Healthcare. 6) Government of Mauritius. 2021. Budget Speech 2021 – 2022 Better Together. 7) International Trade Administration. 2021. Mauritius - Country Commercial Guide Biotechnology. 8) Michael Conway, Tania Holt, Adam Sabow, and Irene Yuan Sun in Mckinsey&Company. 2019. Should sub-Saharan Africa make its own drugs? 9) OECD. 2021. COVID-19 pandemic: Towards a blue recovery in small island developing states. 10) Competition Commission. 2020. Pharmaceutical Industry in Mauritius. 11) 2021. Vaccine and Pharmaceutical Industry in Mauritius. 12) International Finance Corporation (IFC). 2021. Inside Africa’s Push to Make its Own Medicines. 13) International Trade Administration. 2021. Mauritius - Country Commercial Guide Pharmaceuticals. 14) Economic Development Board Mauritius. 2021. Guidelines - Setting Up a Pharmaceutical Manufacturing Unit. 15) UNDP stakeholder consultation with a prominent private medical equipment supplier in Mauritius, conducted on November 30, 2021.
IOA Sources
  • 16) G.R. Modi & Co Chartered Accountants. 2021. Independent Auditor's Report to the Members of Ajanta Pharma (Mauritius) Ltd. (Consolidated). 17) UN Department of Economic and Social Affairs. SDG Indicators (Global) Database. 18) Cambridge University Press. 2021. Sustainable Development Report 2021. 19) Ministry of Health and Quality of Life. 2015. Survey Report 2015 Household Out-of-Pocket Expenditure on Health. 20) Ministry of Industrial Development, SMEs and Cooperatives & United Nations Conference on Trade and Development (UNCTAD). Industrial Policy and Strategic Plan 2020-2025. 21) International Labour Organization. 2004. NATLEX Database of national labor, social security and related human rights legislation Mauritius. 22) UNDP stakeholder consultation with the Mauritian investment promotion agency, conducted in January 31, 2022. 23) UNIDO. 2016. SADC Pharmaceutical Business Plan 2007-2013. 24) Economic Development Board (EDB). 2021. Guidelines - Setting Up a Pharmaceutical Manufacturing Unit. 25) CIDP. Our Location, Mauritius. 26) Ajanta Pharma Limited. Contact Us, Ajanta Pharma (Mauritius) Limited. 27) IBL Group. MedActivity. 28) Statistics Mauritius. August, 2021. Sustainable Development Goals (SDGs) Data/Historical Series.